Galway's Neurent Medical raises $25m in Series B round
Galway’s Neurent Medical raises $25m in Series B round Neurent Medical founders David Townley and Brian Shields. Image: Neurent Medical The company will invest the funds in commercialising its device to treat chronic rhinitis. Galway medtech start-up Neurent Medical has raised $25m in a Series B round to fund its expansion into the US. Neurent develops a device, called Neuromark Rhinitis Neurolysis Therapy, for treating chronic inflammatory sino-nasal conditions. It is now seeking clearance from the Food and Drug Administration (FDA) to commercialise its product in the US market. The fundin...